Press Releases

Upcoming Events

IDWeek 2020
Wednesday, October 21 - Sunday, October 25

Philadelphia, PA

ECCMID 2021
Saturday, April 10 - Tuesday, April 13

Vienna, Austria

> See all Events
June 26, 2010

Venatorx Pharmaceuticals has been awarded an NIH R01 biodefense grant for novel approaches to address resistant category B food and water-borne pathogens. The company may receive up to $4.3M in funding under the grant.

Archive: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010